Skip to content

A Randomized controlled clinical trial for the Analogy choosed external Chinese medicine to treat the psoriasis indications

A Randomized controlled clinical trial for the Analogy choosed external Chinese medicine to treat the psoriasis indications

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16007941
Enrollment
Unknown
Registered
2016-02-17
Start date
2016-03-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

treatment group:External use the basis of the embellish ointment (angelica sinensis, radix arnebiae seu lithospermi), according to the classical theory of ancient books, the basis of the deployment of
control group:Placebo

Sponsors

Beijing Chinese Medicine Hospital affiliated to the Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria :Conform to the diagnostic criteria of psoriasis vulgaris with western medicine; Conform to the psoriasis standards of the blood heat syndrome, blood dryness syndrome and blood stasis syndrome; The age is ranging from 18 to 65 years old; The illness severity: the lesion degree is mild-to-moderate (20 >BSA >5). Sign in the informed consent, volunteer to recept the test, The informed consent process comply with the provisions of the GCP.

Exclusion criteria

Exclusion criteria: Joints psoriasis, pustular psoriasis and erythrodermic psoriasis; the women in Pregnancy or during the lactation period, have fertility plan in three months; Take glucocorticoid and/or immunosuppressive drugs and retinoic acid drugs for nearly one month or exterally use the glucocorticoid agents or drugs such as retinoic acid and vitamin D3 derivative preparation in two weeks; With cardiovascular, cerebrovascular, liver, kidney and hematopoietic system disease and other severe primary diseases and psychosis patients allergy to the study drugs; Taking part in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
Skin lesion area and severity index score (PASI);

Secondary

MeasureTime frame
Dermatology life quality score, SF-36 Quality of Life Scale;The measure of skin barrier function;The major clinical syndromes of traditional Chinese medicine scoring index;auxiliary examination: Blood routine, urine routine, liver function, renal function, electrocardiogram (ecg);History of illness and treatment Onset, family history, history of treatment, and other diseases and treatmenthistory;allergic history: Drugs, food or contact allergy;TCM symptoms, tongue, pulse condition;vital signs: Body temperature, breathing, heart rate, blood pressure;Demographic indicators;

Countries

China

Contacts

Public ContactLi-yun Sun
doctorsunny@sina.cn+86 13521779789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026